Rightway
PrivateLast Round
Series E
Sep 8, 2026
Est. Valuation
$1.75B
Total Funding Raised
$394M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Rightway operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series E round in September 2026.
Rightway is a healthcare technology company that provides care navigation and pharmacy benefit management (PBM) solutions to simplify the healthcare experience for employees and employers.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Patient Engagement, InsurTech
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rightway Comparables
Compare Rightway with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Judi Health | 84% | |
| Transcarent | 83% | |
| SmithRx | 82% |
For institutional investors. Book with your work email.
Rightway Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Sep 8, 2026 | ||||
| Series D | Mar 25, 2024 | ||||
| Series C | Mar 30, 2021 | ||||
| Series B | Nov 21, 2019 | ||||
| Series A | Feb 28, 2019 | ||||
Seed | Nov 8, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Rightway Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Khosla Ventures | Series D, Series E, Series C |
| Thrive Capital | Series D, Series C, Series E, Series B |
| Sempervirens Fund | Series C |
| Tiger Global Management | Series C |
| Francisco Partners | Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 24, 2026
$155M round closed.
- Aug 21, 2026
Monthly visitors increased 42% MoM, reaching 112K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- goes_publicSep 24, 2026
Rightway Healthcare, a pharmacy benefit manager covering about 3 million people, considers an initial public offering in the years ahead as it tries to chip away at a market dominated by large US healthcare conglomerates.
- receives_financingSep 24, 2026
Rightway Healthcare announces $155M in Series E financing led by Francisco Partners, with continued participation from Thrive Capital and Khosla Ventures, on Sep 24th '26.
For institutional investors. Book with your work email.
Rightway Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rightway's valuation, stock price, and market status.
Is Rightway a public or private company?
Rightway is a private company.
What is the current stock price of Rightway?
Rightway is a private company, so its shares have no public market price. Caplight tracks Rightway's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rightway worth (valuation)?
Rightway's valuation is estimated at $1.8B based on funding round data.
Can I buy Rightway stock?
Rightway shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rightway's last funding round?
Rightway's most recent funding round was Series E on September 8, 2026.
Who are the main investors in Rightway?
Key investors in Rightway include Khosla Ventures, Thrive Capital, Francisco Partners.
Will Rightway IPO soon?
No public IPO plans have been announced for Rightway.
How can I track Rightway secondary market activity?
Caplight tracks bids, offers, and trades in Rightway's shares on secondary markets.